International Journal of Infertility & Fetal Medicine

Register      Login

VOLUME 5 , ISSUE 3 ( September-December, 2014 ) > List of Articles

REVIEW ARTICLE

Luteinizing Hormone in Controlled Ovarian Stimulation

Arveen Vohra

Citation Information : Vohra A. Luteinizing Hormone in Controlled Ovarian Stimulation. Int J Infertil Fetal Med 2014; 5 (3):75-86.

DOI: 10.5005/jp-journals-10016-1086

License: CC BY-NC 4.0

Published Online: 01-12-2014

Copyright Statement:  Copyright © 2014; The Author(s).


Abstract

How to cite this article

Vohra A, Rao KA. Luteinizing Hormone in Controlled Ovarian Stimulation. Int J Infertil Fetal Med 2014; 5(3):75-86.


PDF Share
  1. LHR gene expression in human granulosa and cumulus cells from antrel and pre ovulatory follicles. J Clin Endocrinol Metab 2012b Aug;97:E1524-E1531.
  2. Initial and cyclic recruitment of ovarian follicles. Endocr Rev 2000 Apr;21(2):200-214.
  3. Reevaluation of the roles of luteinizing hormone and follicle stimulating hormone in the ovulatory process. Hum Reprod 1991;6(9):1206-1212.
  4. Is luteinizing hormone needed for optimal ovulation induction? Curr Opin Obest Gyncol 2002; 14(3):265-274.
  5. Gonadotropic control of ovarian follicular growth and development. Mol Cell Endocrinol 2001 Jan;179(1-2):39-46.
  6. The clinical therapeutic window for luteinizing hormone in controlled ovarian stimulation. Fertil Steril 2002; 77(6):1170-1177.
  7. Actions of gonadotrophins on the uterus. Reproduction 2001 Jun;121(6):835-842.
  8. Williams Textbook of Endocrinology: 12th ed. Philadelphia, PA: Saunders Elsevier; 2011.
  9. Follicular development induced by recombinant luteinizing hormone (LH) and follicle-stimulating hormone (FSH) in anovulatory women with LH and FSH deficiency: evidence of a threshold effect. Curr Med Res Opin 2008 Oct;24(10):2785-2793.
  10. Use of luteinizing hormone in the treatment of infertility: time for reassessment? American Society for Reproductive Medicine. Fertil Steril 2003 Feb;79(2):253-255.
  11. Compositional analyses of a human menopausal gonadotrophin preparation extracted from urine (menotropin). Identification of some of its major impurities. Reprod Biomed Online 2003 Nov;7(5):547-557.
  12. Efficacy and safety of human menopausal gonadotrophins versus meta-analysis recombinant FSH: a meta-analysis. Reprod BioMed Online 2008 Jan;16(1):81-88.
  13. Urinary hMG versus recombinant FSH for controlled ovarian hyperstimulation following an agonist long down-regulation protocol in IVF or ICSI treatment: a systematic review and meta-analysis. Hum Reprod 2008 Feb;23(2):310-315.
  14. Impact of luteinizing hormone administration on gonadotropin-releasing hormone antagonist cycles: an age-adjusted analysis. Fertil Steril 2011 Mar;95(3):1031-1036.
  15. The use of recombinant luteinizing hormone in patients undergoing assisted reproductive techniques with advanced reproductive age: a systematic review and meta-analysis. Fertil Steril 2012 May; 97(5):1108-1114.
  16. Recombinant human luteinizing hormone (LH) to support recombinant human follicle-stimulating hormone (FSH) induced follicular development in LH- and FSH-deficient anovulatory women: a dose-finding study. J Clin Endocrinol Metab. J Clin Endocrinol Metab 1998;83(5):1507-1514.
  17. Exogenous luteinizing hormone in controlled ovarian hyperstimulation for assisted reproduction techniques. Fertil Steril 2004;82(6): 1521-1526.
  18. Current opinion on use of luteinizing hormone supplementation in assisted reproduction therapy: an Asian perspective. Reprod Biomed Online 2011;23(1):81-90.
  19. Lower apoptosis rate in human cumulus cells after administration of recombinant luteinizing hormone to women undergoing ovarian stimulation for in vitro fertilization procedures. Fertil Steril 2007; 87(3):542-546.
  20. LH supplementation in downregulated women undergoing assisted reproduction with baseline low serum LH levels. Gynecol Endocrinol 2010; 26(2):118-124.
  21. Recombinant LH (lutropin alfa) for the treatment of hypogonadotrophic women with profound LH deficiency: a randomized, double-blind, placebo-controlled, proof-of-efficacy study. Clin Endocrinol 2008 Sep;69(3):471-478.
  22. Lack of association between endogenous LH and pregnancy in GnRH antagonist protocols. Reprod Biomed Online 2011 Dec;23(6):692-694.
  23. Differences in gene expression of granulosa cells from women undergoing controlled ovarian hyperstimulation with either recombinant follicle-stimulating hormone or highly purified human menopausal gonadotropin. Fertil Steril 2009 May;91(5):1820-1830.
  24. on behalf of the recombinant LH study group. Does the addition of recombinant LH in WHO group II anovulatory women over-responding to FSH treatment reduce the number of developing follicles? A dose-finding study. Hum Reprod 2005 Mar;20(3):629-635.
  25. Efficacy of low-dose human chorionic gonadotropin alone to complete controlled ovarian stimulation. Fertil Steril 2005 Aug;84(2):394-401.
  26. Recombinant LH supplementation to recombinant FSH during induced ovarian stimulation in the GnRH-antagonist protocol: a metaanalysis. Reprod Bio Med Online 2007 Jan;14(1):14-25.
  27. Among patients treated with FSH and GnRH analogues for in vitro fertilization, is the addition of recombinant LH associated with the probability of live birth? A systematic review and meta-analysis. Hum Reprod Update 2007 Sep-Oct;13(5):445-452.
  28. Suboptimal response to GnRHa long protocol is associated with a common LH polymorphism. Reprod Biomed Online 2009 Jan;18(1):9-14.
  29. Luteinizing hormone beta-subunit gene (LH beta) polymorphism in infertility and endometriosis-associated infertility. Eur J Obstet Gynecol Reprod Biol 2010;151(1):66-69.
  30. Ovarian response and pregnancy outcome related to mid-follicular LH levels in women undergoing assisted reproduction with GnRH agonist down-regulation and recombinant FSH stimulation. Hum Reprod 2002;17(8):2016-2021.
  31. Luteinizing hormone supplementation increases pregnancy rates in gonadotropinreleasing hormone antagonist donor cycles. Fertil Steril 2004 Aug;82(2):343-347.
  32. Does exogenous LH in ovarian stimulation improve assisted reproduction success? An appraisal of the literature. Reprod Biomed Online 2012; 24(3):261-271.
  33. The use of androgens or androgen-modulating agents in poor responders undergoing in vitro fertilization: a systematic review and meta-analysis. Hum Reprod Update 2012 Mar-Apr;18(2):127-145.
  34. Italian collaborative group on recombinant human luteinizing hormone. Recombinant human LH supplementation versus recombinant human FSH (rFSH) step-up protocol during controlled ovarian stimulation in normogonadotropic women with initial inadequate ovarian response to rFSH. A multicentre, prospective, randomized controlled trial. Hum Reprod 2005; 20(2):390-396.
  35. Combination of recombinant follicle stimulating hormone with human menopausal gonadotrophin or recombinant luteinizing hormone in a long gonadotrophin-releasing hormone agonist protocol: a retrospective study. Reprod Med Biol 2012;11(3):129-133.
  36. Does day 3 luteinizinghormone level predict IVF success in patients undergoing controlled ovarian stimulation with GnRH analogues? Fertil Steril 2008 Oct;90(4):1297-1300.
  37. Is LH necessary in ovulation induction? In: Desai S, Parihar M, Allahabadia G, editors. Infertility: principles and practice. India: BI Publications Pvt Ltd; 2004. p. 5.
  38. Clinical evidence for an LH ceiling effect induced by administration of recombinant human LH during the late follicular phase of stimulated cycles in World Health Organization type I and type II anovulation. Hum Reprod 2003;18(2):314-322.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.